Accession | ARO:3004217 |
Definition | SMB beta-lactamases are a subclass B3 beta-lactamases that hydrolyze a variety of beta-lactams, including penicillins, cephalosporins, and carbapenems. |
Drug Class | carbapenem, cephalosporin, penam |
Resistance Mechanism | antibiotic inactivation |
Classification | 12 ontology terms | Show + process or component of antibiotic biology or chemistry + mechanism of antibiotic resistance + determinant of antibiotic resistance + antibiotic inactivation [Resistance Mechanism] + antibiotic inactivation enzyme + hydrolysis of antibiotic conferring resistance + antibiotic molecule + hydrolysis of beta-lactam antibiotic by metallo-beta-lactamase + beta-lactam antibiotic + beta-lactamase + cephem + class B (metallo-) beta-lactamase |
Parent Term(s) | 4 ontology terms | Show + confers_resistance_to_drug_class carbapenem [Drug Class] + confers_resistance_to_drug_class cephalosporin [Drug Class] + confers_resistance_to_drug_class penam [Drug Class] + subclass B3 (metallo-) beta-lactamase |
Sub-Term(s) | 1 ontology terms | Show + SMB-1 |
Publications | Wachino J, et al. 2012. Acta Crystallogr Sect F Struct Biol Cryst Commun 68(PT 3): 343-346. Crystallization and preliminary X-ray analysis of the subclass B3 metallo-beta-lactamase SMB-1 that confers carbapenem resistance. (PMID 22442240) |